Unum [UNM] vs MetLife [MET] Detailed Stock Comparison

Unum

MetLife
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Unum wins in 12 metrics, MetLife wins in 7 metrics, with 0 ties. Unum appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Unum | MetLife | Better |
---|---|---|---|
P/E Ratio (TTM) | 8.99 | 13.37 | Unum |
Price-to-Book Ratio | 1.14 | 1.90 | Unum |
Debt-to-Equity Ratio | 35.58 | 171.72 | Unum |
PEG Ratio | -1.54 | -0.71 | Unum |
EV/EBITDA | 5.92 | 9.83 | Unum |
Profit Margin (TTM) | 11.77% | 5.87% | Unum |
Operating Margin (TTM) | 13.95% | 5.61% | Unum |
EBITDA Margin (TTM) | 13.95% | 5.61% | Unum |
Return on Equity | 13.95% | 15.51% | MetLife |
Return on Assets (TTM) | 2.14% | 0.59% | Unum |
Free Cash Flow (TTM) | $1.39B | $14.60B | MetLife |
Dividend Yield | 1.61% | 2.10% | MetLife |
1-Year Return | 29.41% | -1.82% | Unum |
Price-to-Sales Ratio (TTM) | 0.99 | 0.72 | MetLife |
Enterprise Value | $13.36B | $71.22B | MetLife |
EV/Revenue Ratio | 1.04 | 0.98 | MetLife |
Revenue per Share (TTM) | $72 | $106 | MetLife |
Earnings per Share (Diluted) | $8.34 | $5.89 | Unum |
Beta (Stock Volatility) | 0.39 | 0.86 | Unum |
Unum vs MetLife Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Unum | 1.05% | 1.34% | 8.55% | -5.21% | -8.93% | 4.07% |
MetLife | -0.82% | 0.65% | -0.63% | 1.70% | -3.80% | -0.98% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Unum | 29.41% | 95.62% | 329.30% | 137.56% | 244.37% | 270.24% |
MetLife | -1.82% | 33.23% | 115.20% | 93.45% | 133.30% | 82.35% |
News Based Sentiment: Unum vs MetLife
Unum
News based Sentiment: MIXED
September presented a mixed bag for Unum, with an earnings miss countered by strong international growth, positive analyst coverage, and proactive risk management through reinsurance. While the earnings miss is a concern, the overall narrative suggests a company actively adapting and returning value to shareholders, making it a moderately significant month for investors.
MetLife
News based Sentiment: MIXED
September presented a mixed bag for MetLife, with positive analyst sentiment and strategic capital management offset by disappointing Q2 earnings. The unsolicited mini-tender offer and its subsequent rejection add another layer to the narrative, highlighting the company's perceived value but also potential vulnerabilities. Overall, the month suggests a company in transition with both opportunities and challenges.
Performance & Financial Health Analysis: Unum vs MetLife
Metric | UNM | MET |
---|---|---|
Market Information | ||
Market Cap | $12.64B | $52.36B |
Market Cap Category | Large cap | Large cap |
10 Day Avg. Volume | 1,759,233 | 2,565,545 |
90 Day Avg. Volume | 1,381,641 | 3,041,258 |
Last Close | $76.70 | $80.32 |
52 Week Range | $57.21 - $84.48 | $65.21 - $89.05 |
% from 52W High | -9.21% | -9.80% |
All-Time High | $84.48 (Mar 24, 2025) | $89.05 (Nov 25, 2024) |
% from All-Time High | -9.21% | -9.80% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.04% | -0.03% |
Quarterly Earnings Growth | -0.14% | -0.23% |
Financial Health | ||
Profit Margin (TTM) | 0.12% | 0.06% |
Operating Margin (TTM) | 0.14% | 0.06% |
Return on Equity (TTM) | 0.14% | 0.16% |
Debt to Equity (MRQ) | 35.58 | 171.72 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $65.76 | $41.52 |
Cash per Share (MRQ) | $20.44 | $45.83 |
Operating Cash Flow (TTM) | $1.58B | $15.23B |
Levered Free Cash Flow (TTM) | $1.58B | $2.87B |
Dividends | ||
Last 12-Month Dividend Yield | 1.61% | 2.10% |
Last 12-Month Dividend | $1.26 | $1.65 |
Valuation & Enterprise Metrics Analysis: Unum vs MetLife
Metric | UNM | MET |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 8.99 | 13.37 |
Forward P/E | 8.29 | 8.12 |
PEG Ratio | -1.54 | -0.71 |
Price to Sales (TTM) | 0.99 | 0.72 |
Price to Book (MRQ) | 1.14 | 1.90 |
Market Capitalization | ||
Market Capitalization | $12.64B | $52.36B |
Enterprise Value | $13.36B | $71.22B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 1.04 | 0.98 |
Enterprise to EBITDA | 5.92 | 9.83 |
Risk & Other Metrics | ||
Beta | 0.39 | 0.86 |
Book Value per Share (MRQ) | $65.76 | $41.52 |
Financial Statements Comparison: Unum vs MetLife
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | UNM | MET |
---|---|---|
Revenue/Sales | $3.35B | $17.16B |
Cost of Goods Sold | N/A | N/A |
Gross Profit | N/A | N/A |
Research & Development | N/A | N/A |
Operating Income (EBIT) | N/A | N/A |
EBITDA | N/A | N/A |
Pre-Tax Income | $417.00M | $980.00M |
Income Tax | $81.40M | $245.00M |
Net Income (Profit) | $335.60M | $735.00M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | UNM | MET |
---|---|---|
Cash & Equivalents | $237.70M | $21.33B |
Total Current Assets | N/A | N/A |
Total Current Liabilities | N/A | N/A |
Long-Term Debt | $3.47B | $18.85B |
Total Shareholders Equity | $11.21B | $27.76B |
Retained Earnings | $13.03B | $43.13B |
Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | UNM | MET |
---|---|---|
Operating Cash Flow | $392.50M | N/A |
Capital Expenditures | $-35.80M | N/A |
Free Cash Flow | $317.80M | $4.26B |
Debt Repayment | N/A | $-810.00M |
Common Stock Repurchase | $-200.50M | $-1.41B |
Short Interest & Institutional Ownership Analysis
Metric | UNM | MET |
---|---|---|
Shares Short | 3.09M | 9.08M |
Short Ratio | 1.92 | 2.60 |
Short % of Float | 0.03% | 0.02% |
Average Daily Volume (10 Day) | 1,759,233 | 2,565,545 |
Average Daily Volume (90 Day) | 1,381,641 | 3,041,258 |
Shares Outstanding | 178.59M | 689.21M |
Float Shares | 154.99M | 554.69M |
% Held by Insiders | 0.01% | 0.00% |
% Held by Institutions | 0.92% | 0.92% |
Dividend Analysis & Yield Comparison: Unum vs MetLife
Metric | UNM | MET |
---|---|---|
Last 12-Month Dividend | $1.26 | $1.65 |
Last 12-Month Dividend Yield | 1.61% | 2.10% |
3-Year Avg Annual Dividend | $1.34 | $1.93 |
3-Year Avg Dividend Yield | 0.76% | 0.77% |
3-Year Total Dividends | $4.02 | $5.78 |
Ex-Dividend Date | Jan 24, 2025 | Feb 04, 2025 |